Sanofi partners with the UAE to advance genomic research and health innovation
Article excerpt
"We are no longer here just to supply medicines into the country; we are here to co-build the future of health alongside the UAE’s leadership."That is the message Baptiste de Clarens, General Manager of Sanofi Greater Gulf, brought to Gulf News on Thursday at the Abu Dhabi Future Health Summit, speaking about Sanofi’s role in the UAE..Last week at the summit the global biopharmaceutical company put its name to a genomic research agreement with Khalifa University, calling it an extension of its long-term commitment to the UAE."More than ever, Sanofi is committed to the UAE for the long term."From supplier to partnerSanofi’s footprint in the UAE is growing, and so is its role. De Clarens said that the company has moved from supplying the country to building alongside it."More than ever, we see the resilience and ambition of the UAE, and we are backing that vision by expanding our scientific and operational footprint across the country.".The concrete elements of that expansion are, according to de Clarens, the regional distribution hub, the collaboration with the Department of Health (DOH) and the clinical research programme."Today, we anchor our regional distribution through our distribution hub here in the UAE, we are collaborating with the DOH to advance vaccine readiness, and we are expanding local research through 26 clinical studies across 32 local sites," he explained...
Keep reading with a free account
The rest of this article, and every signal for Sanofi, is in your free account.
Extracted from this sentence
We signed a new genomic research agreement with Khalifa University to inform future therapeutic discoveries in asthma and COPD, leveraging on the incomparable richness of the UAE Genomic Program," he said.
